Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,484,367
-$1,195,863 QoQ
Shares Held
4,284,662
-4.4% QoQ
Ownership
0.667%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 258 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. GERN ranks #131 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in GERN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,484,367 | 4,284,662 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,680,230 | 4,483,376 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,958,563 | 4,514,063 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,177,967 | 4,509,465 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,611,932 | 4,689,314 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,077,139 | 4,451,031 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $16,014,478 | 4,523,864 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $20,204,734 | 4,450,382 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $18,397,449 | 4,339,021 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $12,836,194 | 3,889,756 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $8,107,675 | 3,842,500 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $7,704,779 | 3,634,330 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,282,493 | 1,334,110 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,470,584 | 1,138,518 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,325,949 | 961,136 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,181,656 | 932,332 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,490,297 | 961,482 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,158,010 | 851,478 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $947,941 | 777,001 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,058,994 | 772,989 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,075,524 | 2,181,223 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,263,916 | 2,065,770 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,203,018 | 2,014,477 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,500,168 | 2,011,591 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,939,787 | 1,807,242 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $1,439,827 | 1,209,939 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||